Financials
- Market Capitalization 24.99 B
- Employee 721
- Founded 2014
- CEO Matt Gline
- Website www.roivant.com
- Headquarter Bermuda
- FIGI N/A
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-51.3
市销率
2 326.88
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 447 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 227.02 USD | -2.43% | +2.66% | -9.25% | -50.88% | 30.38 B USD | ||
| 491 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 57.78 USD | +1.49% | +1.98% | -1.50% | +55.07% | 25.80 B USD | ||
| 523 | UTHR United Therapeutics Corporation - Common Stock | 550.10 USD | +0.17% | +2.66% | +8.57% | +25.67% | 23.59 B USD | ||
| 533 | BNTX BioNTech SE - American Depositary Shares | 95.84 USD | -1.16% | -3.67% | -6.05% | -5.53% | 23.00 B USD |